Clinical Trial Update: Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating nadroparin to improve outcomes after aneurysmal subarachnoid hemorrhage, focusing on delayed cerebral ischemia, and it is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Delayed Cerebral Ischemia

Drugs mentioned

• Nadroparin (nadroparin sodium)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia | Phase 2 | Status: RECRUITING